USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ANDROSCIENCE CORPORATION
City: SAN DIEGO
State: CA
Zip+4: 92121
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (858) 638-7230

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,001.00 2
SBIR Phase II $801,607.00 1
STTR Phase I $99,750.00 1

Award List:

CELL-BASED HIGH THROUGHPUT SCREENING FOR ANTI-ANDROGENS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Charles Shih
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by the applicant): Prostate cancer is the most frequently diagnosed cancer in American men and the second leading cause of male cancer death. Antiandrogens have been used with castration to prevent the progression of prostate cancer. However, cancer relapse… More

ANTI-ANDROGENIC MECHANISM OF A NEW COMPOUND

Award Year / Program / Phase: 2002 / STTR / Phase I
Agency: HHS
Research Institution: George Whipple Laboratory for Cancer Research
Principal Investigator: Charles C. Shih
Award Amount: $99,750.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Androgen blockage therapy may relieve the symptom of an advanced, localized prostate tumor; however, once the tumor evolves into a hormone-refractory stage, there is no effective treatment. A continuous activation of AR by antiandrogens (used in androgen blockage… More

A New Topical Antiandrogen Benefits Acne Treatment

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Charles C. Shih
Award Amount: $100,001.00
Abstract:
DESCRIPTION (provided by applicant): Acne is the most common skin disorder encountered by physicians. It affects 80% of all persons between the ages of 11 and 30 years. Although the overall health is not impaired, acne can produce cutaneous and emotional scars that last a lifetime. Currently… More

A New Topical Antiandrogen Benefits Acne Treatment

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Charles C. Shih
Award Amount: $801,607.00
Abstract:
DESCRIPTION (provided by applicant): Acne is the second most expensive skin disease, resulting in $2.23 billion in medical spending annually. Although the overall health is not impaired, acne can produce cutaneous and emotional scars that last a lifetime. It is not surprising that there is high… More